medigraphic.com

2014, Number 1

<< Back Next >>

Rev Fac Med UNAM 2014; 57 (1)

Ovarian cancer, the assault by an invisible murderer

Gaona ER

Language: Spanish
References: 15
Page: 24-30
PDF size: 536.44 Kb.


ABSTRACT

Ovarian cancer develops from three kinds of cells: epithelial cells, germ cells, and stromal cells. About 90% of ovarian cancer is of the epithelial kind, thus being the most frequent of the three histological types and, unfortunately, one of the main causes of death by female reproductive system cancer; due to the insidious and unspecific symptomatology of this disease, which, regrettably, has an extremely high mortality. The incidence of this kind of lineage increases with age and, unlike germ and stromal cancers, it is rare before the fifth decade of life.
It is important to know that in Mexico as well as in the rest of the world, that the incidence of the different varieties of the histological subtype of ovarian epithelial cancer is as follows: serous (60-80%), mucinous (10-25%), endometrioid (8-20%), clear cells (5%), Brenner tumor (<1%) and not differentiated. Epithelial-serous ovarian cancer is the most frequent in the world; therefore, the one we fear hunts most of our women.


REFERENCES

  1. Gallardo RD, Cantú de León D, Alaníz LP, Álvarez AMA,Bañuelos FJ, Herbert-Núñez GS, et al. Tercer ConsensoNacional de Cáncer de Ovario 2011. Grupo de Investigaciónde Cáncer de Ovario y Tumores Ginecológicos enMéxico “GICOM”. Rev Inv Clin. 2011;63(6):665-702.

  2. Fauci A, Braunwald E, Kasper DL, Hauser SL, Longo,DL, Jameson JL, et al. Harrison’s Principles of InternalMedicine. New York: McGraw-Hill; 2009. pp 604-6.

  3. Kerlikowske K, Brown JS, Grady DG. Should women withfamilial ovarian cancer undergo prophylactic oophorectomy?Obstet Gynecol. 1992;80:700.

  4. Goff B. Symptoms Associated With Ovarian Cancer. ClinicalObstetrics and Gynecology. 2012;55(1):36-42.

  5. Goff BA, Mandel L, Muntz HG, et al. Ovarian carcinomadiagnosis. Cancer. 2000;89:2068-75.

  6. Berek JS. Ginecología de Novak. 14ª Edición. España:Wolters Kuwer Health España, S.A., Lippincott Williams& Wilkins; 2008.

  7. Schorge JO, Shaffer JI, Halverson LM, et al. WilliamsGinecología. México DF: Mc.Graw- Hill Interamericana;2009.

  8. Sayasneh A, Tsivos D, Crawford R. Endometriosis andovarian cancer: a systematic review. ISRN Obstet Gynecol.2011;2011:140-310.

  9. Kondi-Pafiti A, Papakonstantinou E, Lavazzo C, et al.Clinicopathological characteristics of ovarian carcinomasassociated with endometriosis. Arch GynecolObstet. 2011.

  10. Jelovac D, Armstrong DK. Recent progress in the diagnosisand treatment of ovarian cancer. CA Cancer J Clin. 2011;61:183-203.

  11. Havrilesky LJ, Sanders GD, Kulasingam S, et al. Developmentof an ovarian cancer screening decision model thatincorporates disease heterogeneity. Cancer. 2011;117:545-53.

  12. Rosenthal AN, Menon U, Jacobs IJ. Screening for ovariancancer. Clin Obstet Gynecol. 2006;49:433.

  13. Olsen CM, Green AC, Whiteman DC, et al. Obesity andthe risk of epithelial ovarian cancer: a systematic reviewand meta-analysis. Eur J Cancer. 2007;43:690-709.

  14. Purdie DM, Siskind V, Bain CJ, et al. Body size and ovariancancer: case-control study and systematic review. CancerCauses Control. 2001;12:855-63.

  15. Kushi LH, Mink PJ, Sellers TA, et al. Prospective study ofdiet and ovarian cancer. Am J Epidemiol. 1999;149:21-31.




2020     |     www.medigraphic.com